Novavax, Inc. (NVAX)

Last Closing Price: 3.97 (2024-04-19)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Novavax, Inc. (NVAX) had Revenue of $291.34M for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
Revenue
$291.34M
$-178.39M
$154.98M
$136.37M
$474.91M
$-183.57M
$6.87M
$-176.70M
$-176.70M
$-178.39M
$-178.39M
$-178.39M
$-178.39M
$-183.57M
$-172.77M
100.77M
100.77M
$-1.39
$-1.32
Balance Sheet Financials
$1.14B
$305.77M
$653.60M
$1.80B
$1.64B
$223.94M
$879.28M
$2.51B
$-716.93M
$-844.38M
$-716.93M
139.51M
Cash Flow Statement Financials
$-713.97M
$-58.81M
$4.47M
$1.35B
$583.81M
$-765.03M
$85.36M
--
--
Fundamental Metrics & Ratios
0.70
--
--
-0.45
-0.32
46.81%
-63.01%
-63.01%
--
-60.65%
-61.23%
$-767.74M
--
--
--
0.16
3.72
0.98
91.82
24.88%
21.13%
-9.92%
36.19%
$-5.14
$-7.62
$-7.09